First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer
具有针对结直肠癌的临床前活性的首创致癌 CHD1L 抑制剂
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-20-0106
Joshua M Abbott, Qiong Zhou, Hector Esquer, Laura Pike, Travis P Broneske, Sébastien Rinaldetti, Adedoyin D Abraham, Dominique A Ramirez, Paul J Lunghofer, Todd M Pitts, Daniel P Regan, Aik Choon Tan, Daniel L Gustafson, Wells A Messersmith, Daniel V LaBarbera